首页> 外文期刊>Bioactive Materials >Advances in 3D bioprinting technology for cardiac tissue engineering and regeneration
【24h】

Advances in 3D bioprinting technology for cardiac tissue engineering and regeneration

机译:3D生物监控技术的进步心脏组织工程和再生技术

获取原文
           

摘要

Cardiovascular disease is still one of the leading causes of death in the world, and heart transplantation is the current major treatment for end-stage cardiovascular diseases. However, because of the shortage of heart donors, new sources of cardiac regenerative medicine are greatly needed. The prominent development of tissue engineering using bioactive materials has creatively laid a direct promising foundation. Whereas, how to precisely pattern a cardiac structure with complete biological function still requires technological breakthroughs. Recently, the emerging three-dimensional (3D) bioprinting technology for tissue engineering has shown great advantages in generating micro-scale cardiac tissues, which has established its impressive potential as a novel foundation for cardiovascular regeneration. Whether 3D bioprinted hearts can replace traditional heart transplantation as a novel strategy for treating cardiovascular diseases in the future is a frontier issue. In this review article, we emphasize the current knowledge and future perspectives regarding available bioinks, bioprinting strategies and the latest outcome progress in cardiac 3D bioprinting to move this promising medical approach towards potential clinical implementation.
机译:心血管疾病仍然是世界上死亡的主要原因之一,心脏移植是目前终级心血管疾病的主要治疗。然而,由于心脏捐赠者短缺,很有需要新的心脏再生医学来源。使用生物活性材料的组织工程突出的发展创造性地铺设了直接的承诺基础。虽然,如何精确地模式完全生物功能的心脏结构仍需要技术突破。最近,用于组织工程的新兴三维(3D)生物制版技术在发电微级心脏组织方面表现出了很大的优势,这使得其作为心血管再生的新基础建立了令人印象深刻的潜力。 3D Bioplinted Hearts是否可以将传统的心脏移植取代作为治疗未来心血管疾病的新策略是一个前沿问题。在本文中,我们强调了关于可用生物链接,生物监测策略以及心脏3D生物制品的最新结果进展的现有知识和未来的观点,以使这一有希望的医学方法趋于潜在的临床实施。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号